Sandoz : EMA Accepts MAA For Proposed Biosimilar Denosumab
25/5 07:27
(RTTNews) - Sandoz, a Novartis (NVS) division engaged in generic pharmaceuticals and biosimilars, said Thursday that the European Medicines Agency has accepted the marketing authorization applications for proposed biosimilar denosumab for regulatory review....